Search

Your search keyword '"Doolan, Denise L"' showing total 726 results
Start Over Author "Doolan, Denise L"
726 results on '"Doolan, Denise L"'

2. Novel antiinflammatory biologics shaped by parasite—host coevolution

Author

Ryan, Stephanie M., Ruscher, Roland, Johnston, Wayne A., Pickering, Darren A., Kennedy, Malcolm W., Smith, Brian O., Jones, Linda, Buitrago, Geraldine, Field, Matt A., Esterman, Adrian J., McHugh, Connor P., Browne, Daniel J., Cooper, Martha M., Ryan, Rachael Y. M., Doolan, Denise L., Engwerda, Christian R., Miles, Kim, Mitreva, Makedonka, Croese, John, Rahman, Tony, Alexandrov, Kirill, Giacomin, Paul R., and Loukas, Alex

Published
2022

4. Identification of Cytauxzoon felis antigens via protein microarray and assessment of expression library immunization against cytauxzoonosis

Author

Schreeg, Megan E, Marr, Henry S, Tarigo, Jaime L, Sherrill, Meredith K, Outi, Hilton K, Scholl, Elizabeth H, Bird, David M, Vigil, Adam, Hung, Chris, Nakajima, Rie, Liang, Li, Trieu, Angela, Doolan, Denise L, Thomas, Jennifer E, Levy, Michael G, Reichard, Mason V, Felgner, Philip L, Cohn, Leah A, and Birkenheuer, Adam J

Subjects
Biochemistry and Cell Biology, Biological Sciences, Orphan Drug, Rare Diseases, Biotechnology, Immunization, Vaccine Related, Prevention, Infectious Diseases, Genetics, Prevention of disease and conditions, and promotion of well-being, 3.4 Vaccines, Infection, Good Health and Well Being, Cytauxzoonosis, Cytauxzoon felis, Expression library immunization, Protein microarray, Piroplasmid, Vaccine, Biochemistry & Molecular Biology, Biochemistry and cell biology, Clinical sciences, Medical biochemistry and metabolomics
Abstract

BackgroundCytauxzoonosis is a disease of felids in North America caused by the tick-transmitted apicomplexan parasite Cytauxzoon felis. Cytauxzoonosis is particularly virulent for domestic cats, but no vaccine currently exists. The parasite cannot be cultivated in vitro, presenting a significant limitation for vaccine development.MethodsRecent sequencing of the C. felis genome has identified over 4300 putative protein-encoding genes. From this pool we constructed a protein microarray containing 673 putative C. felis proteins. This microarray was probed with sera from C. felis-infected and naïve cats to identify differentially reactive antigens which were incorporated into two expression library vaccines, one polyvalent and one monovalent. We assessed the efficacy of these vaccines to prevent of infection and/or disease in a tick-challenge model.ResultsProbing of the protein microarray resulted in identification of 30 differentially reactive C. felis antigens that were incorporated into the two expression library vaccines. However, expression library immunization failed to prevent infection or disease in cats challenged with C. felis.ConclusionsProtein microarray facilitated high-throughput identification of novel antigens, substantially increasing the pool of characterized C. felis antigens. These antigens should be considered for development of C. felis vaccines, diagnostics, and therapeutics.

Published
2018

8. Suboptimal SARS-CoV-2−specific CD8⁺ T cell response associated with the prominent HLA-A*02 : 01 phenotype

Author

Habel, Jennifer R., Nguyen, Thi H. O., van de Sandt, Carolien E., Juno, Jennifer A., Chaurasia, Priyanka, Wragg, Kathleen, Koutsakos, Marios, Hensen, Luca, Jia, Xiaoxiao, Chua, Brendon, Zhang, Wuji, Tan, Hyon-Xhi, Flanagan, Katie L., Doolan, Denise L., Torresi, Joseph, Chen, Weisan, Wakim, Linda M., Cheng, Allen C., Doherty, Peter C., Petersen, Jan, Rossjohn, Jamie, Wheatley, Adam K., Kent, Stephen J., Rowntree, Louise C., and Kedzierska, Katherine

Published
2020

9. A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2

Author

Fulford, Thomas S., Van, Huy, Gherardin, Nicholas A., Zheng, Shuning, Ciula, Marcin, Drummer, Heidi E., Redmond, Samuel, Tan, Hyon-Xhi, Boo, Irene, Center, Rob J., Li, Fan, Grimley, Samantha L., Wines, Bruce D., Nguyen, Thi H.O., Mordant, Francesca L., Ellenberg, Paula, Rowntree, Louise C., Kedzierski, Lukasz, Cheng, Allen C., Doolan, Denise L., Matthews, Gail, Bond, Katherine, Hogarth, P. Mark, McQuilten, Zoe, Subbarao, Kanta, Kedzierska, Katherine, Juno, Jennifer A., Wheatley, Adam K., Kent, Stephen J., Williamson, Deborah A., Purcell, Damian F.J., Anderson, David A., and Godfrey, Dale I.

Published
2021
Full Text
View/download PDF

11. Immunomics-guided discovery of serum and urine antibodies for diagnosing urogenital schistosomiasis: a biomarker identification study

Author

Pearson, Mark S, Tedla, Bemnet A, Mekonnen, Gebeyaw G, Proietti, Carla, Becker, Luke, Nakajima, Rie, Jasinskas, Al, Doolan, Denise L, Amoah, Abena S, Knopp, Stefanie, Rollinson, David, Ali, Said M, Kabole, Fatma, Hokke, Cornelis H, Adegnika, Akim A, Field, Matt A, van Dam, Govert, Corstjens, Paul L A M, Mduluza, Takafira, Mutapi, Francisca, Oeuvray, Claude, Greco, Beatrice, Chaiyadet, Sujittra, Laha, Thewarach, Cai, Pengfei, McManus, Donald P, Bottazzi, Maria Elena, Felgner, Philip L, Sotillo, Javier, and Loukas, Alex

Published
2021
Full Text
View/download PDF

13. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity

Author

Nguyen, Thi H.O., Rowntree, Louise C., Petersen, Jan, Chua, Brendon Y., Hensen, Luca, Kedzierski, Lukasz, van de Sandt, Carolien E., Chaurasia, Priyanka, Tan, Hyon-Xhi, Habel, Jennifer R., Zhang, Wuji, Allen, Lilith F., Earnest, Linda, Mak, Kai Yan, Juno, Jennifer A., Wragg, Kathleen, Mordant, Francesca L., Amanat, Fatima, Krammer, Florian, Mifsud, Nicole A., Doolan, Denise L., Flanagan, Katie L., Sonda, Sabrina, Kaur, Jasveen, Wakim, Linda M., Westall, Glen P., James, Fiona, Mouhtouris, Effie, Gordon, Claire L., Holmes, Natasha E., Smibert, Olivia C., Trubiano, Jason A., Cheng, Allen C., Harcourt, Peter, Clifton, Patrick, Crawford, Jeremy Chase, Thomas, Paul G., Wheatley, Adam K., Kent, Stephen J., Rossjohn, Jamie, Torresi, Joseph, and Kedzierska, Katherine

Published
2021
Full Text
View/download PDF

14. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

Author

Koutsakos, Marios, Rowntree, Louise C., Hensen, Luca, Chua, Brendon Y., van de Sandt, Carolien E., Habel, Jennifer R., Zhang, Wuji, Jia, Xiaoxiao, Kedzierski, Lukasz, Ashhurst, Thomas M., Putri, Givanna H., Marsh-Wakefield, Felix, Read, Mark N., Edwards, Davis N., Clemens, E. Bridie, Wong, Chinn Yi, Mordant, Francesca L., Juno, Jennifer A., Amanat, Fatima, Audsley, Jennifer, Holmes, Natasha E., Gordon, Claire L., Smibert, Olivia C., Trubiano, Jason A., Hughes, Carly M., Catton, Mike, Denholm, Justin T., Tong, Steven Y.C., Doolan, Denise L., Kotsimbos, Tom C., Jackson, David C., Krammer, Florian, Godfrey, Dale I., Chung, Amy W., King, Nicholas J.C., Lewin, Sharon R., Wheatley, Adam K., Kent, Stephen J., Subbarao, Kanta, McMahon, James, Thevarajan, Irani, Nguyen, Thi H.O., Cheng, Allen C., and Kedzierska, Katherine

Published
2021
Full Text
View/download PDF

18. Development and validation of serological markers for detecting recent Plasmodium vivax infection

Author

Longley, Rhea J., White, Michael T., Takashima, Eizo, Brewster, Jessica, Morita, Masayuki, Harbers, Matthias, Obadia, Thomas, Robinson, Leanne J., Matsuura, Fumie, Liu, Zoe S.J., Li-Wai-Suen, Connie, Tham, Wai-Hong, Healer, Julie, Huon, Christine, Chitnis, Chetan E., Nguitragool, Wang, Monteiro, Wuelton, Proietti, Carla, Doolan, Denise L., Siqueira, Andre M., Ding, Xavier C., Gonzalez, Iveth J., Kazura, James, Lacerda, Marcus, Sattabongkot, Jetsumon, Tsuboi, Takafumi, and Mueller, Ivo

Subjects
Control, Testing, Diagnosis, Methods, Malaria -- Diagnosis -- Control, Serologic tests -- Methods, Biological markers -- Testing -- Methods, Plasmodium vivax -- Testing -- Methods, Serodiagnosis -- Methods
Abstract

Author(s): Rhea J. Longley [sup.1] [sup.2] [sup.3] , Michael T. White [sup.4] , Eizo Takashima [sup.5] , Jessica Brewster [sup.1] , Masayuki Morita [sup.5] , Matthias Harbers [sup.6] [sup.7] , [...], A major gap in the Plasmodium vivax elimination toolkit is the identification of individuals carrying clinically silent and undetectable liver-stage parasites, called hypnozoites. This study developed a panel of serological exposure markers capable of classifying individuals with recent P. vivax infections who have a high likelihood of harboring hypnozoites. We measured IgG antibody responses to 342 P. vivax proteins in longitudinal clinical cohorts conducted in Thailand and Brazil and identified candidate serological markers of exposure. Candidate markers were validated using samples from year-long observational cohorts conducted in Thailand, Brazil and the Solomon Islands and antibody responses to eight P. vivax proteins classified P. vivax infections in the previous 9 months with 80% sensitivity and specificity. Mathematical models demonstrate that a serological testing and treatment strategy could reduce P. vivax prevalence by 59-69%. These eight antibody responses can serve as a biomarker, identifying individuals who should be targeted with anti-hypnozoite therapy. Plasmodium vivax can cause a clinically silent liver-stage infection that can reactivate, triggering blood-stage disease. A new test measuring antibody responses can identify P. vivax carriers for targeted treatment intervention.

Published
2020
Full Text
View/download PDF

22. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma

Author

Liu, Zhiwei, Sarathkumara, Yomani D., Chan, John K. C., Kwong, Yok-Lam, Lam, Tai Hing, Ip, Dennis Kai Ming, Chiu, Brian C.-H., Xu, Jun, Su, Yu-Chieh, Proietti, Carla, Cooper, Martha M., Yu, Kelly J., Bassig, Bryan, Liang, Raymond, Hu, Wei, Ji, Bu-Tian, Coghill, Anna E., Pfeiffer, Ruth M., Hildesheim, Allan, Rothman, Nathaniel, Doolan, Denise L., and Lan, Qing

Published
2021
Full Text
View/download PDF

23. Systems serology detects functionally distinct coronavirus antibody features in children and elderly

Author

Selva, Kevin J., van de Sandt, Carolien E., Lemke, Melissa M., Lee, Christina Y., Shoffner, Suzanne K., Chua, Brendon Y., Davis, Samantha K., Nguyen, Thi H. O., Rowntree, Louise C., Hensen, Luca, Koutsakos, Marios, Wong, Chinn Yi, Mordant, Francesca, Jackson, David C., Flanagan, Katie L., Crowe, Jane, Tosif, Shidan, Neeland, Melanie R., Sutton, Philip, Licciardi, Paul V., Crawford, Nigel W., Cheng, Allen C., Doolan, Denise L., Amanat, Fatima, Krammer, Florian, Chappell, Keith, Modhiran, Naphak, Watterson, Daniel, Young, Paul, Lee, Wen Shi, Wines, Bruce D., Mark Hogarth, P., Esterbauer, Robyn, Kelly, Hannah G., Tan, Hyon-Xhi, Juno, Jennifer A., Wheatley, Adam K., Kent, Stephen J., Arnold, Kelly B., Kedzierska, Katherine, and Chung, Amy W.

Published
2021
Full Text
View/download PDF

25. A Novel Candidate Vaccine for Cytauxzoonosis Inferred from Comparative Apicomplexan Genomics

Author

Tarigo, Jaime L, Scholl, Elizabeth H, Bird, David McK., Brown, Corrie C, Cohn, Leah A, Dean, Gregg A, Levy, Michael G, Doolan, Denise L, Trieu, Angela, Nordone, Shila K, Felgner, Philip L, Vigil, Adam, Birkenheuer, Adam J, and Ho, Paulo Lee

Subjects
Theileria-Parva Sporozoites, Domestic Cats, Babesia-Bovis, Fatal Cytauxzoonosis, Blood-Samples, Felis, Infection, Disease, Microarrays, Annulataperfluorooctane sulfonate pfos, serum concentrations, association, disease, population, adults, permeability, elimination, mortality, community
Published
2013

26. Schistosomiasis vaccine discovery using immunomics

Author

Driguez, Patrick, Doolan, Denise L., Loukas, Alex, Felgner, Philip L., and McManus, Donald P.

Subjects
infection, microarrays, antigens, genomics, proteome
Abstract

The recent publication of the Schistosoma japonicum and S. mansoni genomes has expanded greatly the opportunities for post-genomic schistosomiasis vaccine research. Immunomics protein microarrays provide an excellent application of this new schistosome sequence information, having been utilised successfully for vaccine antigen discovery with a range of bacterial and viral pathogens, and malaria. Accordingly, we have designed and manufactured a Schistosoma immunomics protein microarray as a vaccine discovery tool. The microarray protein selection combined previously published data and in silico screening of available sequences for potential immunogens based on protein location, homology to known protective antigens, and high specificity to schistosome species. Following cloning, selected sequences were expressed cell-free and contact-printed onto nitrocellulose microarrays. The reactivity of microarray proteins with antisera from schistosomiasis-exposed/resistant animals or human patients can be measured with labelled secondary antibodies and a laser microarray scanner; highly reactive proteins can be further assessed as putative vaccines. This highly innovative technology has the potential to transform vaccine research for schistosomiasis and other parasitic diseases of humans and animals.

Published
2010

30. Technical pitfalls when collecting, cryopreserving, thawing, and stimulating human T-cells.

Author

Browne, Daniel J., Miller, Catherine M., and Doolan, Denise L.

Subjects
MONONUCLEAR leukocytes, THAWING, T cells
Abstract

The collection, cryopreservation, thawing, and culture of peripheral blood mononuclear cells (PBMCs) can profoundly influence T cell viability and immunogenicity. Gold-standard PBMC processing protocols have been developed by the Office of HIV/AIDS Network Coordination (HANC); however, these protocols are not universally observed. Herein, we have explored the current literature assessing how technical variation during PBMC processing can influence cellular viability and T cell immunogenicity, noting inconsistent findings between many of these studies. Amid the mounting concerns over scientific replicability, there is growing acknowledgement that improved methodological rigour and transparent reporting is required to facilitate independent reproducibility. This review highlights that in human T cell studies, this entails adopting stringent standardised operating procedures (SOPs) for PBMC processing. We specifically propose the use of HANC's Cross-Network PBMC Processing SOP, when collecting and cryopreserving PBMCs, and the HANC member network International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) PBMC Thawing SOP when thawing PBMCs. These stringent and detailed protocols include comprehensive reporting procedures to document unavoidable technical variations, such as delayed processing times. Additionally, we make further standardisation and reporting recommendations to minimise and document variability during this critical experimental period. This review provides a detailed overview of the challenges inherent to a procedure often considered routine, highlighting the importance of carefully considering each aspect of SOPs for PBMC collection, cryopreservation, thawing, and culture to ensure accurate interpretation and comparison between studies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

Author

Argirion, Ilona, Pfeiffer, Ruth M., Proietti, Carla, Coghill, Anna E., Yu, Kelly J., Middeldorp, Jaap M., Sarathkumara, Yomani D., Hsu, Wan-Lun, Chien, Yin-Chu, Lou, Pei-Jen, Wang, Cheng-Ping, Rothman, Nathaniel, Lan, Qing, Chen, Chien-Jen, Mbulaiteye, Sam M., Jarrett, Ruth F., Glimelius, Ingrid, Smedby, Karin E., Hjalgrim, Henrik, Hildesheim, Allan, Doolan, Denise L., Liu, Zhiwei, Argirion, Ilona, Pfeiffer, Ruth M., Proietti, Carla, Coghill, Anna E., Yu, Kelly J., Middeldorp, Jaap M., Sarathkumara, Yomani D., Hsu, Wan-Lun, Chien, Yin-Chu, Lou, Pei-Jen, Wang, Cheng-Ping, Rothman, Nathaniel, Lan, Qing, Chen, Chien-Jen, Mbulaiteye, Sam M., Jarrett, Ruth F., Glimelius, Ingrid, Smedby, Karin E., Hjalgrim, Henrik, Hildesheim, Allan, Doolan, Denise L., and Liu, Zhiwei

Abstract

Background: Epstein-Barr virus (EBV) is linked to multiple cancers, including classical Hodgkin lymphoma (cHL), endemic Burkitt lymphoma (eBL), nasopharyngeal carcinoma (NPC), and extranodal natural killer/T-cell lymphoma (NKTCL). Methods: Anti-EBV IgG and IgA antibody responses target-ing 202 sequences from 86 EBV proteins were measured using the same EBV whole proteome array across four case-control studies investigating EBV-positive cHL, eBL, NPC, and NKTCL (407 cases/620 controls). We grouped EBV-targeted antibodies into pathways by immunoglobulin type (IgA and IgG) and life-cycle stage (latent, immediate early lytic, early lytic, late lytic, and glycoprotein) and evaluated their associ-ation with each cancer type. In an additional analysis, we focused on the subset of 46 individual antibodies repre-senting the top candidates for each cancer and compared their associations across the four cancer types using multivariable linear regression models. Results: IgA antibody responses targeting all EBV life-cycle stages were associated with NPC but limited to anti-early lytic stage for cHL. NPC and eBL were associated with IgG antibodies across the viral life cycle; cHL with antibodies in the early lytic, late lytic and glyco-protein stages; and NKTCL with antibodies in the latent, immediate early lytic and early lytic phases. EBNA3A, BBLF1, BDLF4, and BLRF2 IgG antibodies were associated with all cancer types.Conclusions: Our observed similarities and differences across four EBV-associated cancers may inform EBV-related oncogenesis. Impact: Understanding the comparative humoral immune response across EBV-related cancers may aid in identifying shared etiologic roles of EBV proteins and inform unique pathogenic processes for each cancer.

Published
2023
Full Text
View/download PDF

36. Data from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

Author

Argirion, Ilona, primary, Pfeiffer, Ruth M., primary, Proietti, Carla, primary, Coghill, Anna E., primary, Yu, Kelly J., primary, Middeldorp, Jaap M., primary, Sarathkumara, Yomani D., primary, Hsu, Wan-Lun, primary, Chien, Yin-Chu, primary, Lou, Pei-Jen, primary, Wang, Cheng-Ping, primary, Rothman, Nathaniel, primary, Lan, Qing, primary, Chen, Chien-Jen, primary, Mbulaiteye, Sam M., primary, Jarrett, Ruth F., primary, Glimelius, Ingrid, primary, Smedby, Karin E., primary, Hjalgrim, Henrik, primary, Hildesheim, Allan, primary, Doolan, Denise L., primary, and Liu, Zhiwei, primary

Published
2023
Full Text
View/download PDF

37. Supplementary Table S2 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

Author

Argirion, Ilona, primary, Pfeiffer, Ruth M., primary, Proietti, Carla, primary, Coghill, Anna E., primary, Yu, Kelly J., primary, Middeldorp, Jaap M., primary, Sarathkumara, Yomani D., primary, Hsu, Wan-Lun, primary, Chien, Yin-Chu, primary, Lou, Pei-Jen, primary, Wang, Cheng-Ping, primary, Rothman, Nathaniel, primary, Lan, Qing, primary, Chen, Chien-Jen, primary, Mbulaiteye, Sam M., primary, Jarrett, Ruth F., primary, Glimelius, Ingrid, primary, Smedby, Karin E., primary, Hjalgrim, Henrik, primary, Hildesheim, Allan, primary, Doolan, Denise L., primary, and Liu, Zhiwei, primary

Published
2023
Full Text
View/download PDF

38. Supplementary Methods S1 from Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

Author

Argirion, Ilona, primary, Pfeiffer, Ruth M., primary, Proietti, Carla, primary, Coghill, Anna E., primary, Yu, Kelly J., primary, Middeldorp, Jaap M., primary, Sarathkumara, Yomani D., primary, Hsu, Wan-Lun, primary, Chien, Yin-Chu, primary, Lou, Pei-Jen, primary, Wang, Cheng-Ping, primary, Rothman, Nathaniel, primary, Lan, Qing, primary, Chen, Chien-Jen, primary, Mbulaiteye, Sam M., primary, Jarrett, Ruth F., primary, Glimelius, Ingrid, primary, Smedby, Karin E., primary, Hjalgrim, Henrik, primary, Hildesheim, Allan, primary, Doolan, Denise L., primary, and Liu, Zhiwei, primary

Published
2023
Full Text
View/download PDF

41. Figure S3 from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

Author

Coghill, Anna E., primary, Pfeiffer, Ruth M., primary, Proietti, Carla, primary, Hsu, Wan-Lun, primary, Chien, Yin-Chu, primary, Lekieffre, Lea, primary, Krause, Lutz, primary, Teng, Andy, primary, Pablo, Jocelyn, primary, Yu, Kelly J., primary, Lou, Pei-Jen, primary, Wang, Cheng-Ping, primary, Liu, Zhiwei, primary, Chen, Chien-Jen, primary, Middeldorp, Jaap, primary, Mulvenna, Jason, primary, Bethony, Jeff, primary, Hildesheim, Allan, primary, and Doolan, Denise L., primary

Published
2023
Full Text
View/download PDF

42. Tables S2-S4 from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

Author

Coghill, Anna E., primary, Pfeiffer, Ruth M., primary, Proietti, Carla, primary, Hsu, Wan-Lun, primary, Chien, Yin-Chu, primary, Lekieffre, Lea, primary, Krause, Lutz, primary, Teng, Andy, primary, Pablo, Jocelyn, primary, Yu, Kelly J., primary, Lou, Pei-Jen, primary, Wang, Cheng-Ping, primary, Liu, Zhiwei, primary, Chen, Chien-Jen, primary, Middeldorp, Jaap, primary, Mulvenna, Jason, primary, Bethony, Jeff, primary, Hildesheim, Allan, primary, and Doolan, Denise L., primary

Published
2023
Full Text
View/download PDF

43. Supplemental Methods from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

Author

Coghill, Anna E., primary, Pfeiffer, Ruth M., primary, Proietti, Carla, primary, Hsu, Wan-Lun, primary, Chien, Yin-Chu, primary, Lekieffre, Lea, primary, Krause, Lutz, primary, Teng, Andy, primary, Pablo, Jocelyn, primary, Yu, Kelly J., primary, Lou, Pei-Jen, primary, Wang, Cheng-Ping, primary, Liu, Zhiwei, primary, Chen, Chien-Jen, primary, Middeldorp, Jaap, primary, Mulvenna, Jason, primary, Bethony, Jeff, primary, Hildesheim, Allan, primary, and Doolan, Denise L., primary

Published
2023
Full Text
View/download PDF

44. Table S1 from Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

Author

Coghill, Anna E., primary, Pfeiffer, Ruth M., primary, Proietti, Carla, primary, Hsu, Wan-Lun, primary, Chien, Yin-Chu, primary, Lekieffre, Lea, primary, Krause, Lutz, primary, Teng, Andy, primary, Pablo, Jocelyn, primary, Yu, Kelly J., primary, Lou, Pei-Jen, primary, Wang, Cheng-Ping, primary, Liu, Zhiwei, primary, Chen, Chien-Jen, primary, Middeldorp, Jaap, primary, Mulvenna, Jason, primary, Bethony, Jeff, primary, Hildesheim, Allan, primary, and Doolan, Denise L., primary

Published
2023
Full Text
View/download PDF

45. Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies

Author

Argirion, Ilona, primary, Pfeiffer, Ruth M., additional, Proietti, Carla, additional, Coghill, Anna E., additional, Yu, Kelly J., additional, Middeldorp, Jaap M., additional, Sarathkumara, Yomani D., additional, Hsu, Wan-Lun, additional, Chien, Yin-Chu, additional, Lou, Pei-Jen, additional, Wang, Cheng-Ping, additional, Rothman, Nathaniel, additional, Lan, Qing, additional, Chen, Chien-Jen, additional, Mbulaiteye, Sam M., additional, Jarrett, Ruth F., additional, Glimelius, Ingrid, additional, Smedby, Karin E., additional, Hjalgrim, Henrik, additional, Hildesheim, Allan, additional, Doolan, Denise L., additional, and Liu, Zhiwei, additional

Published
2023
Full Text
View/download PDF

46. Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions

Author

Lam, W K Jacky, primary, King, Ann D, additional, Miller, Jacob A, additional, Liu, Zhiwei, additional, Yu, Kelly J, additional, Chua, Melvin L K, additional, Ma, Brigette B Y, additional, Chen, Ming Yuan, additional, Pinsky, Benjamin A, additional, Lou, Pei-Jen, additional, Woo, John K S, additional, Hsu, Wan-Lun, additional, Simon, Julia, additional, Doolan, Denise L, additional, Waterboer, Tim, additional, Hui, Edwin P, additional, Li, Hui, additional, Tsang, Raymond K, additional, Wong, Kenneth C W, additional, Goh, Julian P, additional, Vlantis, Alexander C, additional, Ai, Qi Yong, additional, Wong, Lun M, additional, Abdullah, Victor, additional, Lin, Jin Ching, additional, Chen, Chien-Jen, additional, Pfeiffer, Ruth M, additional, Le, Quynh-Thu, additional, Lee, Anne W M, additional, Ji, Mingfang, additional, Cao, Sumei, additional, Ma, Jun, additional, Chan, Anthony T C, additional, Chan, K C Allen, additional, and Hildesheim, Allan, additional

Published
2023
Full Text
View/download PDF

49. High production of pro-inflammatory cytokines by maternal blood mononuclear cells is associated with reduced maternal malaria but increased cord blood infection

Author

Dobaño, Carlota, Berthoud, Tamara, Manaca, Maria Nelia, Nhabomba, Augusto, Guinovart, Caterina, Aguilar, Ruth, Barbosa, Arnoldo, Groves, Penny, Rodríguez, Mauricio H., Jimenez, Alfons, Quimice, Lazaro M., Aponte, John J., Ordi, Jaume, Doolan, Denise L., Mayor, Alfredo, and Alonso, Pedro L.

Published
2018
Full Text
View/download PDF

50. Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease

Author

Ratnatunga, Champa N., primary, Tungatt, Katie, additional, Proietti, Carla, additional, Halstrom, Sam, additional, Holt, Michael R., additional, Lutzky, Viviana P., additional, Price, Patricia, additional, Doolan, Denise L., additional, Bell, Scott C., additional, Field, Matt A., additional, Kupz, Andreas, additional, Thomson, Rachel M., additional, and Miles, John J., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results